A variety of cancer cell types are deficient in ATM, forcing them to upregulate ATR to maintain cell viability.6 , 15 , 16 ATR inhibition in ATM-deficient cell lines results in synthetic lethality and renders these tumors more susceptible to DNA-damaging chemotherapies.18 This evidence concerns the gene ATR and cancer.